secwatch.observer — SEC 8-K summary
======================================

Issuer:     Translational Development Acquisition Corp. (TDAC)
CIK:        0001926599
Form:       8-K
Filed at:   2024-12-31T23:59:59+00:00
Accession:  0001104659-24-132921
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SPAC Translational Development closes $172.5M IPO; auditor flags going concern
------------------------------------------------------------------------------

- IPO of 17,250,000 units at $10.00/unit (including over-allotment), gross proceeds $172.5M.
- Private placement of 7,075,000 warrants at $1.00 each to sponsor and underwriter, gross $7.075M.
- Net proceeds $174,225,000 deposited into trust account; trust balance $174,225,000 as of Dec 24, 2024.
- Auditor's going concern opinion: company lacks capital to sustain operations for one year from Dec 24, 2024.
- Cash on hand $949,060; working capital $508,361; shareholders' deficit ($5,529,139).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1926599/000110465924132921/0001104659-24-132921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1926599/000110465924132921/tm2432245d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-132921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer